Żelazny, P., Filipczak, J., Sygacz, O., Bróż, S., Dankiewicz, S., Swora, A., Borowik, J., Brodowski, W., Pawłowski, P., & Basta-Arciszewska, K. (2022). Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF). Journal of Education, Health and Sport, 12(9), 583–588. https://doi.org/10.12775/JEHS.2022.12.09.068